124 related articles for article (PubMed ID: 1716644)
1. Influence of chlorthalidone on the pharmacokinetics and pharmacodynamics of Org 10172 (Lomoparan), a low molecular weight heparinoid, in healthy volunteers.
de Boer A; Stiekema JC; Danhof M; Breimer DD
J Clin Pharmacol; 1991 Jul; 31(7):611-7. PubMed ID: 1716644
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the combined medication with the new low-molecular-weight heparinoid Lomoparan (Org 10172) and acenocoumarol.
Stiekema JC; de Boer A; Danhof M; Kroon C; Broekmans AW; van Dinther TG; Voerman J; Breimer DD
Haemostasis; 1990; 20(3):136-46. PubMed ID: 1696921
[TBL] [Abstract][Full Text] [Related]
3. Interaction of ORG 10172, a low molecular weight heparinoid, and digoxin in healthy volunteers.
de Boer A; Stiekema JC; Danhof M; Moolenaar AJ; Breimer DD
Eur J Clin Pharmacol; 1991; 41(3):245-50. PubMed ID: 1748141
[TBL] [Abstract][Full Text] [Related]
4. The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172.
De Boer A; Stiekema JC; Danhof M; Breimer DD
Br J Clin Pharmacol; 1991 Jul; 32(1):23-9. PubMed ID: 1716140
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic considerations on Orgaran (Org 10172) therapy.
Danhof M; de Boer A; Magnani HN; Stiekema JC
Haemostasis; 1992; 22(2):73-84. PubMed ID: 1379967
[TBL] [Abstract][Full Text] [Related]
6. Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.
Stiekema JC; Wijnand HP; Van Dinther TG; Moelker HC; Dawes J; Vinchenzo A; Toeberich H
Br J Clin Pharmacol; 1989 Jan; 27(1):39-48. PubMed ID: 2468354
[TBL] [Abstract][Full Text] [Related]
7. Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers.
de Boer A; Danhof M; Cohen AF; Magnani HN; Breimer DD
Thromb Haemost; 1991 Aug; 66(2):202-7. PubMed ID: 1722918
[TBL] [Abstract][Full Text] [Related]
8. Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers.
de Boer A; Stiekema JC; Danhof M; van Dinther TG; Boeijinga JK; Cohen AF; Breimer DD
Antimicrob Agents Chemother; 1991 Oct; 35(10):2110-5. PubMed ID: 1759835
[TBL] [Abstract][Full Text] [Related]
9. ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man.
Bradbrook ID; Magnani HN; Moelker HC; Morrison PJ; Robinson J; Rogers HJ; Spector RG; Van Dinther T; Wijnand H
Br J Clin Pharmacol; 1987 Jun; 23(6):667-75. PubMed ID: 3606928
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM
Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213
[TBL] [Abstract][Full Text] [Related]
11. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate.
ten Cate H; Henny CP; ten Cate JW; Büller HR; Dabhoiwala NF
Thromb Haemost; 1987 Feb; 57(1):92-6. PubMed ID: 2438799
[TBL] [Abstract][Full Text] [Related]
13. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.
Henny CP; Ten Cate H; Ten Cate JW; Moulijn AC; Sie TH; Warren P; Büller HR
J Lab Clin Med; 1985 Aug; 106(2):187-96. PubMed ID: 4020247
[TBL] [Abstract][Full Text] [Related]
14. A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models.
Meuleman DG; Hobbelen PM; van Dedem G; Moelker HC
Thromb Res; 1982 Aug; 27(3):353-63. PubMed ID: 6182627
[TBL] [Abstract][Full Text] [Related]
15. Partial in vivo neutralisation of plasma anticoagulant effects of Lomoparan (Org 10172) by protamine chloride.
Stiekema JC; Wijnand HP; ten Cate H; ten Cate JW; Harenberg J; Egberts JF; van Dinther TG
Thromb Res; 1991 Jul; 63(1):157-67. PubMed ID: 1948817
[TBL] [Abstract][Full Text] [Related]
16. Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise.
de Boer A; Kluft C; Dooijewaard G; Kasper FJ; Kroon JM; Breimer DD; Stiekema JC; Cohen AF
Thromb Haemost; 1992 Nov; 68(5):550-5. PubMed ID: 1280862
[TBL] [Abstract][Full Text] [Related]
17. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.
Keeling DM; Richards EM; Baglin TP
Br J Haematol; 1994 Feb; 86(2):425-6. PubMed ID: 7515270
[TBL] [Abstract][Full Text] [Related]
18. The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessment.
Ireland H; Lane DA; Flynn A; Anastassiades E; Curtis JR
Thromb Haemost; 1986 Apr; 55(2):271-5. PubMed ID: 3715791
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation following intravenous injection of a conventional heparin: absence of effect with a low molecular weight heparinoid (Org 10172).
Mikhailidis DP; Fonseca VA; Barradas MA; Jeremy JY; Dandona P
Br J Clin Pharmacol; 1987 Oct; 24(4):415-24. PubMed ID: 3689624
[TBL] [Abstract][Full Text] [Related]
20. A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke.
Biller J; Massey EW; Marler JR; Adams HP; Davis JN; Bruno A; Henriksen RA; Linhardt RJ; Goldstein LB; Alberts M
Neurology; 1989 Feb; 39(2 Pt 1):262-5. PubMed ID: 2464774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
